Hip fracture is one of the most devastating medical events in older adults — with one-year mortality rates of 20 to 30 percent and permanent loss of independence in 40 percent of survivors. Osteoporosis affects 200 million people worldwide and is almost entirely preventable with appropriate intervention begun in the third and fourth decades of life. Bone density is a longevity biomarker that most adults ignore until it is too late.
The skeleton is not a passive scaffold for the body's soft tissues. Bone is a living, metabolically active organ that participates in mineral homeostasis, hematopoiesis, endocrine signaling (via osteocalcin, which influences insulin sensitivity, energy metabolism, and cognition), and immune function. Its deterioration — osteoporosis — is a silent process that accelerates across decades without symptoms until the first fracture occurs. By that point, the opportunity for primary prevention has passed.1
Bone tissue is continuously remodeled through the coupled activity of osteoclasts (bone resorbing cells, derived from hematopoietic precursors) and osteoblasts (bone forming cells, derived from mesenchymal stem cells). In young adults, formation and resorption are approximately balanced, maintaining bone mass. After approximately age 35, a gradual imbalance develops in which resorption progressively exceeds formation — producing a slow but continuous net bone loss of approximately 0.5 to 1 percent per year in men and pre-menopausal women.2
The menopause transition produces a dramatic acceleration of this imbalance: estrogen is a critical regulator of osteoclast activity, and its withdrawal removes the primary brake on bone resorption. Women lose 2 to 3 percent of bone mass per year in the 5 to 10 years following menopause, with the most rapid loss occurring in the first 3 to 5 years. This is why HRT, if initiated within the timing window, is the most effective intervention for menopause-related bone loss — reducing fracture risk by approximately 30 to 40 percent in RCT data.
Not all exercise is equivalent for bone health. Walking, swimming, and cycling — though excellent for cardiovascular fitness — provide minimal mechanical stimulus for bone density preservation because the ground reaction forces and bone strain they generate are below the threshold required for osteogenic adaptation. The exercises with the strongest osteogenic stimulus are those that generate high-magnitude, rapidly applied forces: resistance training with heavy loads (squats, deadlifts, overhead press), jumping and plyometric training, and loaded carries.3
The Bone Estrogen Strength Training (BEST) trial randomized postmenopausal women to resistance training or control for one year and found significant improvements in lumbar spine bone density in the resistance training group. The LIFTMOR trial (high-intensity resistance training in postmenopausal women with osteopenia) produced T-score improvements of 2.9 percent at the lumbar spine and 0.3 percent at the femoral neck — clinically meaningful effects from 8 months of twice-weekly training. The key osteogenic exercises: back squat, deadlift, overhead press, weighted vest walking, and impact activities such as jumping rope or jumping jacks.
Calcium (1,000 to 1,200 mg/day from food and supplements combined) provides the mineral substrate for bone matrix. Vitamin D (target 25-OH-D of 40 to 60 ng/mL) is required for intestinal calcium absorption. These are the foundations — but several additional nutrients are critically important and frequently overlooked. Protein provides the collagen matrix that gives bone its structural resilience. Low protein intake is associated with reduced bone density and elevated fracture risk in observational data, and adequate protein (1.2 to 2.0 g/kg/day) supports bone formation alongside calcium and vitamin D. Vitamin K2 (MK-7 form, 100 to 200 mcg/day) activates osteocalcin — the protein that incorporates calcium into the bone crystal lattice — and carboxylates matrix Gla protein, which prevents calcium from depositing in arteries. Multiple RCTs show that vitamin K2 supplementation improves bone density and reduces fracture risk. Magnesium (300 to 400 mg/day) is required for vitamin D activation and hydroxylation and is a structural component of the hydroxyapatite crystal that constitutes bone mineral.4
DEXA (dual-energy X-ray absorptiometry) measures bone mineral density at the lumbar spine and proximal femur and provides T-scores (standard deviations below peak young adult bone density) that classify normal (above -1.0), osteopenia (-1.0 to -2.5), and osteoporosis (below -2.5) status. Current guidelines recommend DEXA for all women over 65, all men over 70, and younger adults with significant risk factors. Many longevity physicians recommend baseline DEXA in the 40s to establish trajectory and identify early osteopenia while interventions can be most effective.5
